Litigation for DAPAGLIFLOZIN PROPANEDIOL; SAXAGLIPTIN HYDROCHLORIDE
✉ Email this page to a colleague
US Court Litigation for DAPAGLIFLOZIN PROPANEDIOL; SAXAGLIPTIN HYDROCHLORIDE
| Patent | Case Name | Docket | Date Filed | Date Terminated | Cause | Court | Jury Demand | Link To Docket |
|---|---|---|---|---|---|---|---|---|
| 6,414,126 | ⤷ Sign Up | ⤷ Sign Up | 2018-05-01 | 2022-07-28 | 35:271 Patent Infringement | District Court, D. Delaware | None | ⤷ Sign Up |
| 6,414,126 | ⤷ Sign Up | ⤷ Sign Up | 2023-02-23 | District Court, D. Delaware | ⤷ Sign Up | |||
| 6,414,126 | ⤷ Sign Up | ⤷ Sign Up | 2017-07-07 | 15:1126 Patent Infringement | District Court, D. New Jersey | None | ⤷ Sign Up | |
| >Patent | >Case Name | >Docket | >Date Filed | >Date Terminated | >Cause | >Court | >Jury Demand | >Link To Docket |
Patent Trial and Appeal Board Cases for DAPAGLIFLOZIN PROPANEDIOL; SAXAGLIPTIN HYDROCHLORIDE
| Patent | Petitioner | Status | Filing Date | Accorded Filing Date | Patent Owner | Trial Type | Trial Number | Decision Date | Inventor | Document Download |
|---|---|---|---|---|---|---|---|---|---|---|
| RE44,186 | Mylan Pharmaceuticals Inc. | ⤷ Sign Up | 2015-06-04 | 06-04-2015 | AstraZeneca AB | Inter partes review | ⤷ Sign Up | 05-02-2016 | Jeffrey Robl | ⤷ Sign Up |
| RE44,186 | Wockhardt Bio AG | ⤷ Sign Up | 2016-05-11 | 05-11-2016 | AstraZeneca AB | Inter partes review | ⤷ Sign Up | 08-23-2016 | Jeffrey Robl | ⤷ Sign Up |
| RE44,186 | Amneal Pharmaceuticals LLC et al. | ⤷ Sign Up | 2016-06-01 | 06-03-2016 | AstraZeneca AB | Inter partes review | ⤷ Sign Up | 11-22-2016 | Jeffrey Robl | ⤷ Sign Up |
| >Patent | >Petitioner | >Status | >Filing Date | >Accorded Filing Date | >Patent Owner | >Trial Type | >Trial Number | >Decision Date | >Inventor | >Document Download |
